相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers
Qingyang Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield et al.
CELL (2021)
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects
Spyridoula Vasileiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages
Chaoran Zang et al.
BMC CANCER (2021)
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Jong-Mu Sun et al.
LANCET (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma
Amanda J. Craig et al.
PLOS GENETICS (2021)
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy
Martin Thelen et al.
NPJ PRECISION ONCOLOGY (2021)
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
Mikiya Ishihara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson et al.
NUCLEIC ACIDS RESEARCH (2020)
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Vid Leko et al.
CANCER CELL (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma
Premal D. Lulla et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Gal Cafri et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Regulation of Gene Expression of Cancer/Testis Antigens in Colorectal Cancer Patients
D. S. Kutilin
MOLECULAR BIOLOGY (2020)
Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
Yangying Zhou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
A Phase I Pharmacokinetic (PK) and Safety Study of Trph-222 in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL): Dose-Escalation Results
Francisco J. Hernandez-Ilizaliturri et al.
BLOOD (2020)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Monika Brueggemann et al.
LEUKEMIA (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Lu Huang et al.
CLINICAL CANCER RESEARCH (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Target Antigen Downregulation and Other Mechanisms of Failure after Axicabtagene Ciloleucel (CAR19) Therapy
Jean Oak et al.
BLOOD (2018)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen
Nobue Futawatari et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy
Kerstin Wennhold et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer
Seyer Safi et al.
ONCOIMMUNOLOGY (2017)
KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer.
Charles S. Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma
Nathan Singh et al.
ONCOIMMUNOLOGY (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma
Stefani Spranger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response
Christina Pfirschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
Matthias Obenaus et al.
NATURE BIOTECHNOLOGY (2015)
Single-cell transcriptome analysis reveals coordinated ectopic gene-expression patterns in medullary thymic epithelial cells
Philip Brennecke et al.
NATURE IMMUNOLOGY (2015)
Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer
Kimberly E. Maxfield et al.
NATURE COMMUNICATIONS (2015)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jerome Galon et al.
JOURNAL OF PATHOLOGY (2014)
Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapy
Anna Babiak et al.
ONCOLOGY REPORTS (2014)
Tumor Subtype-Specific Cancer-Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
Jun Yao et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression
J. Liang et al.
BRITISH JOURNAL OF CANCER (2013)
Heterogeneous Expression of CT10, CT45 and GAGE7 Antigens and their Prognostic Significance in Human Breast Carcinoma
Xingchun Zhou et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
Takemasa Tsuji et al.
ONCOIMMUNOLOGY (2012)
Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2011)
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
Jianda Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Expression of Cancer-Testis Antigens MAGE-A3/6 and NY-ESO-1 in Non-Small-Cell Lung Carcinomas and Their Relationship with Immune Cell Infiltration
Sang Hyun Kim et al.
LUNG (2009)
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy
Vaios Karanikas et al.
CANCER BIOLOGY & THERAPY (2008)
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma
Andreas Mackensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters
J Gotter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
NY-ESO-1 expression and immunogenicity in esophageal cancer
S Fujita et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
